These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22633899)

  • 1. Poly-lactide-co-glycolide nanoparticles containing voriconazole for pulmonary delivery: in vitro and in vivo study.
    Sinha B; Mukherjee B; Pattnaik G
    Nanomedicine; 2013 Jan; 9(1):94-104. PubMed ID: 22633899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary Delivery of Voriconazole Loaded Nanoparticles Providing a Prolonged Drug Level in Lungs: A Promise for Treating Fungal Infection.
    Das PJ; Paul P; Mukherjee B; Mazumder B; Mondal L; Baishya R; Debnath MC; Dey KS
    Mol Pharm; 2015 Aug; 12(8):2651-64. PubMed ID: 25941882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
    Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
    J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary delivery of deslorelin: large-porous PLGA particles and HPbetaCD complexes.
    Koushik K; Dhanda DS; Cheruvu NP; Kompella UB
    Pharm Res; 2004 Jul; 21(7):1119-26. PubMed ID: 15290850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan-coated nanoparticles enhanced lung pharmacokinetic profile of voriconazole upon pulmonary delivery in mice.
    Paul P; Sengupta S; Mukherjee B; Shaw TK; Gaonkar RH; Debnath MC
    Nanomedicine (Lond); 2018 Mar; 13(5):501-520. PubMed ID: 29383985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aerosolizable modified-release particles of montelukast improve retention and availability of the drug in the lungs.
    Patel B; Rashid J; Ahsan F
    Eur J Pharm Sci; 2017 Jan; 96():560-570. PubMed ID: 27989858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles.
    Panyam J; Sahoo SK; Prabha S; Bargar T; Labhasetwar V
    Int J Pharm; 2003 Aug; 262(1-2):1-11. PubMed ID: 12927382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonazepam release from poly(DL-lactide-co-glycolide) nanoparticles prepared by dialysis method.
    Nah JW; Paek YW; Jeong YI; Kim DW; Cho CS; Kim SH; Kim MY
    Arch Pharm Res; 1998 Aug; 21(4):418-22. PubMed ID: 9875469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of nanoparticles containing an antihypertensive agent.
    Leroueil-Le Verger M; Fluckiger L; Kim YI; Hoffman M; Maincent P
    Eur J Pharm Biopharm; 1998 Sep; 46(2):137-43. PubMed ID: 9795032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and in vitro evaluation of surface modified poly(lactide-co-glycolide) nanoparticles with chitosan-4-thiobutylamidine.
    Grabovac V; Bernkop-Schnürch A
    Drug Dev Ind Pharm; 2007 Jul; 33(7):767-74. PubMed ID: 17654025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4.
    Wang M; Zhang Y; Feng J; Gu T; Dong Q; Yang X; Sun Y; Wu Y; Chen Y; Kong W
    Int J Nanomedicine; 2013; 8():1141-54. PubMed ID: 23658482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems.
    Semete B; Booysen L; Lemmer Y; Kalombo L; Katata L; Verschoor J; Swai HS
    Nanomedicine; 2010 Oct; 6(5):662-71. PubMed ID: 20230912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and in-vitro/in-vivo evaluation of surface-modified poly (lactide-co-glycolide) fluorescent nanoparticles.
    Pamujula S; Hazari S; Bolden G; Graves RA; Chinta DM; Dash S; Kishore V; Mandal TK
    J Pharm Pharmacol; 2010 Apr; 62(4):422-9. PubMed ID: 20604830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Albumin-coated porous hollow poly(lactic-co-glycolic acid) microparticles bound with palmityl-acylated exendin-4 as a long-acting inhalation delivery system for the treatment of diabetes.
    Kim H; Lee J; Kim TH; Lee ES; Oh KT; Lee DH; Park ES; Bae YH; Lee KC; Youn YS
    Pharm Res; 2011 Aug; 28(8):2008-19. PubMed ID: 21472489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of biodegradable polymer based tamoxifen citrate loaded nanoparticles and effect of some manufacturing process parameters on them: a physicochemical and in-vitro evaluation.
    Sahana B; Santra K; Basu S; Mukherjee B
    Int J Nanomedicine; 2010 Sep; 5():621-30. PubMed ID: 20856837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant encapsulated porous poly(lactide-co-glycolide) microparticles for developing long acting inhalation system.
    Yoo NY; Youn YS; Oh NM; Oh KT; Lee DK; Cha KH; Oh YT; Lee ES
    Colloids Surf B Biointerfaces; 2011 Nov; 88(1):419-24. PubMed ID: 21820282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of highly porous large PLGA microparticles for pulmonary drug delivery.
    Yang Y; Bajaj N; Xu P; Ohn K; Tsifansky MD; Yeo Y
    Biomaterials; 2009 Apr; 30(10):1947-53. PubMed ID: 19135245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of novel spray-dried polymeric particles for controlled pulmonary drug delivery.
    Beck-Broichsitter M; Schweiger C; Schmehl T; Gessler T; Seeger W; Kissel T
    J Control Release; 2012 Mar; 158(2):329-35. PubMed ID: 22063006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cationic surface modification of PLG nanoparticles offers sustained gene delivery to pulmonary epithelial cells.
    Baoum A; Dhillon N; Buch S; Berkland C
    J Pharm Sci; 2010 May; 99(5):2413-22. PubMed ID: 19911425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib-loaded poly(D,L-lactide-co-glycolide) nanoparticles prepared using a novel and controllable combination of diffusion and emulsification steps as part of the salting-out procedure.
    McCarron PA; Donnelly RF; Marouf W
    J Microencapsul; 2006 Aug; 23(5):480-98. PubMed ID: 16980271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.